[News Brief] Datar Cancer Genetics Secures US FDA Clearance for Assay
Datar Cancer Genetics has received US Food and Drug Administration clearance for CellDx-Tissue, a tissue-based comprehensive genomic profiling assay designed…
Press Release
[News Brief] Nuance Pharma Secures IND Approval for Actair® Trial
Nuance Pharma has received Investigational New Drug (IND) clearance from China’s National Medical Products Administration to begin a Phase III…
[News Brief] HKSAR Government Promotes Health Innovation in Switzerland
The Secretary for Health of Hong Kong SAR, Professor Lo Chung-mau, met multinational pharmaceutical and healthcare companies in Zurich, Switzerland…
[News Brief] Zylox-Tonbridge to Acquire Equity Interest in Optimed
Zylox-Tonbridge has entered into a definitive agreement to acquire a Germany-based medical technology company, Optimed Medizinische Instrumente GmbH, in multiple…
[News Brief] IHH Healthcare Secures Sustainability-Linked Loan from DBS
IHH Healthcare has secured a SGD 250 million sustainability-linked loan from DBS Bank to support corporate purposes and advance its…
[News Brief] QuantumTx and NUH Launch Muscle Health Centre
QuantumTx and the National University Hospital (NUH) have launched the QuantumTx-NUH MitoCharge Muscle Health Centre, a facility focused on muscle…
[News Brief] IMH and NTU Study Identifies Blood Markers Linked to Psychosis Risk
A study by the Institute of Mental Health (IMH) and Nanyang Technological University (NTU) has identified blood-based protein markers associated…
[News Brief] AstraZeneca Enters Licensing Agreement with CSPC Pharmaceuticals
AstraZeneca has entered into a strategic collaboration with CSPC Pharmaceutical Group to obtain ex-China rights to a weight management portfolio…
[News Brief] GSK Enters Strategic Collaboration with SBP Group
GSK plc has entered into an exclusive strategic collaboration with Sino Biopharmaceutical (SBP Group), through its subsidiary Chia Tai Tianqing…
[News Brief] Amplexd Therapeutics Starts Phase 2 HPV Trial
Amplexd Therapeutics has received authorisation from the Hong Kong Department of Health to begin a Phase 2 trial of an…